Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
VINAY GUPTA. M.D.(Psych.) Dip.,C.A.P., Reader, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab.
Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on